Curriculum · Musculoskeletal / Orthopedic / Rheumatology
Localised scleroderma (morphea)
What it is
Generalized morphea is not systemic sclerosis. Morphea is limited to the skin, while systemic sclerosis affects the internal organs, and that single line is what separates the two. The weight of that line is in what systemic sclerosis then carries: its major cause of death is the heart, the lung and the kidney, and its treatment is tailored to the organ system involved - good skin hygiene with low dose prednisone and methotrexate (limited evidence) for the skin, cold avoidance and vasodilators for Raynaud, PPIs then H2 receptor agonists for reflux, broad spectrum antibiotics for small bowel bacterial overgrowth, ACE inhibitors for renal disease, systemic steroids for pericarditis and for myositis, and bosentan, epoprostenol or sildenafil for pulmonary hypertension. Morphea, being limited to the skin, carries none of that organ list.
How it presents
Generalized morphea appears in the skin, and it is limited to the skin. Diffuse edema of the hands, firm and thickened skin, flexion contractures of the fingers, and Raynaud's phenomenon in its pallor phase are set beside it as separate findings and are not morphea; what morphea is set against is systemic sclerosis, which affects the internal organs.